Literature DB >> 19920770

Successful clinical islet isolation using a GMP-manufactured collagenase and neutral protease.

Gregory L Szot1, Michael R Lee, Mohammad M Tavakol, Jiena Lang, Florinna Dekovic, Robert K Kerlan, Peter G Stock, Andrew M Posselt.   

Abstract

In 2007, the islet community was notified that the collagenase product most commonly used for human islet isolations contained bovine neural tissue contaminants. To minimize this potential hazard, we adapted our human islet processing procedure to use a GMP-manufactured, bovine neural tissue-free collagenase blend. Here, we describe the factors that we consider most important for achieving reproducible and clinically useable islet isolations using this product.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19920770      PMCID： PMC2782539          DOI： 10.1097/TP.0b013e3181b443ae

Source DB:  PubMed          Journal:  Transplantation        ISSN： 0041-1337            Impact factor:   4.939


  16 in total

1.  Factors affecting human islet of Langerhans isolation yields.

Authors:  C Toso; J Oberholzer; F Ris; F Triponez; P Bucher; A Demirag; E Andereggen; L Buehler; N Cretin; B Fournier; P Majno; Y Hong; J Lou; P Morel
Journal:  Transplant Proc       Date:  2002-05       Impact factor: 1.066

2.  The effect of two-layer (University of Wisconsin solution/perfluorochemical) preservation method on clinical grade pancreata prior to islet isolation and transplantation.

Authors:  S Matsumoto; G Zhang; S Qualley; J Clever; Y Tombrello; D M Strong; J A Reems
Journal:  Transplant Proc       Date:  2004-05       Impact factor: 1.066

3.  Large-scale purification of human islets utilizing discontinuous albumin gradient on IBM 2991 cell separator.

Authors:  S P Lake; P D Bassett; A Larkins; J Revell; K Walczak; J Chamberlain; G M Rumford; N J London; P S Veitch; P R Bell
Journal:  Diabetes       Date:  1989-01       Impact factor: 9.461

4.  Automated method for isolation of human pancreatic islets.

Authors:  C Ricordi; P E Lacy; E H Finke; B J Olack; D W Scharp
Journal:  Diabetes       Date:  1988-04       Impact factor: 9.461

5.  Successful single donor islet allotransplantation in the streptozotocin diabetes rat model.

Authors:  Henning Jahr; Birte Hussmann; Torsten Eckhardt; Reinhard G Bretzel
Journal:  Cell Transplant       Date:  2002       Impact factor: 4.064

6.  Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen.

Authors:  A M Shapiro; J R Lakey; E A Ryan; G S Korbutt; E Toth; G L Warnock; N M Kneteman; R V Rajotte
Journal:  N Engl J Med       Date:  2000-07-27       Impact factor: 91.245

7.  Human islet transplantation: lessons from 13 autologous and 13 allogeneic transplantations.

Authors:  J Oberholzer; F Triponez; R Mage; E Andereggen; L Bühler; N Crétin; B Fournier; C Goumaz; J Lou; J Philippe; P Morel
Journal:  Transplantation       Date:  2000-03-27       Impact factor: 4.939

8.  Serva collagenase NB1: a new enzyme preparation for human islet isolation.

Authors:  P Bucher; Z Mathe; D Bosco; A Andres; M Kurfuerst; N Rämsch-Günther; L Buhler; Ph Morel; T Berney
Journal:  Transplant Proc       Date:  2004-05       Impact factor: 1.066

9.  Percutaneous transhepatic pancreatic islet cell transplantation in type 1 diabetes mellitus: radiologic aspects.

Authors:  Richard J T Owen; Edmond A Ryan; Kevin O'Kelly; Jonathan R T Lakey; Mairin C McCarthy; Breay W Paty; David L Bigam; Norman M Kneteman; Gregory S Korbutt; Ray V Rajotte; A M James Shapiro
Journal:  Radiology       Date:  2003-08-27       Impact factor: 11.105

10.  Transplantation of cultured islets from two-layer preserved pancreases in type 1 diabetes with anti-CD3 antibody.

Authors:  Bernhard J Hering; Raja Kandaswamy; James V Harmon; Jeffrey D Ansite; Sue M Clemmings; Tetsuya Sakai; Stephen Paraskevas; Peter M Eckman; Junichiro Sageshima; Masahiko Nakano; Toshiya Sawada; Ippei Matsumoto; Hui J Zhang; David E R Sutherland; Jeffrey A Bluestone
Journal:  Am J Transplant       Date:  2004-03       Impact factor: 8.086
View more
  24 in total

1.  Experience of islet isolation without neutral protease supplementation.

Authors:  Tatsuya Kin; Doug O'Gorman; Peter Senior; A M James Shapiro
Journal:  Islets       Date:  2010-09-01       Impact factor: 2.694

2.  A new enzyme mixture to increase the yield and transplant rate of autologous and allogeneic human islet products.

Authors:  A N Balamurugan; Gopalakrishnan Loganathan; Melena D Bellin; Joshua J Wilhelm; James Harmon; Takayuki Anazawa; Sajjad M Soltani; David M Radosevich; Takeshi Yuasa; Mukesh Tiwari; Klearchos K Papas; Robert McCarthy; David E R Sutherland; Bernhard J Hering
Journal:  Transplantation       Date:  2012-04-15       Impact factor: 4.939

3.  Islet transplantation in type 1 diabetic patients using calcineurin inhibitor-free immunosuppressive protocols based on T-cell adhesion or costimulation blockade.

Authors:  Andrew M Posselt; Gregory L Szot; Lynda A Frassetto; Umesh Masharani; Mehdi Tavakol; Raj Amin; Joan McElroy; Marissa D Ramos; Robert K Kerlan; Lawrence Fong; Flavio Vincenti; Jeffrey A Bluestone; Peter G Stock
Journal:  Transplantation       Date:  2010-12-27       Impact factor: 4.939

4.  Update on islet cell transplantation for type 1 diabetes.

Authors:  Avinash Agarwal; Kenneth L Brayman
Journal:  Semin Intervent Radiol       Date:  2012-06       Impact factor: 1.513

5.  Different digestion enzymes used for human pancreatic islet isolation: a mixed treatment comparison (MTC) meta-analysis.

Authors:  Jakeline Rheinheimer; Patrícia Klarmann Ziegelmann; Rodrigo Carlessi; Luciana Ross Reck; Andrea Carla Bauer; Cristiane Bauermann Leitão; Daisy Crispim
Journal:  Islets       Date:  2014-11-07       Impact factor: 2.694

Review 6.  Islet transplantation in type 1 diabetes: ongoing challenges, refined procedures, and long-term outcome.

Authors:  A M James Shapiro
Journal:  Rev Diabet Stud       Date:  2012-12-28

7.  Pancreas-After-Islet Transplantation in Nonuremic Type 1 Diabetes: A Strategy for Restoring Durable Insulin Independence.

Authors:  S A Wisel; J M Gardner; G R Roll; J Harbell; C E Freise; S Feng; S M Kang; R Hirose; D B Kaufman; A M Posselt; P G Stock
Journal:  Am J Transplant       Date:  2017-06-06       Impact factor: 8.086

8.  The Choice of Enzyme for Human Pancreas Digestion is a Critical Factor for Increasing the Success of Islet Isolation.

Authors:  Meirigeng Qi; Luis Valiente; Brian McFadden; Keiko Omori; Shiela Bilbao; Jemily Juan; Jeffrey Rawson; Stephen Scott; Kevin Ferreri; Yoko Mullen; Mohamed El-Shahawy; Donald Dafoe; Fouad Kandeel; Ismail H Al-Abdullah
Journal:  Transplant Direct       Date:  2015-05

9.  A Comparative Analysis of the Safety, Efficacy, and Cost of Islet Versus Pancreas Transplantation in Nonuremic Patients With Type 1 Diabetes.

Authors:  S Moassesfar; U Masharani; L A Frassetto; G L Szot; M Tavakol; P G Stock; A M Posselt
Journal:  Am J Transplant       Date:  2015-11-23       Impact factor: 8.086

10.  Identifying Effective Enzyme Activity Targets for Recombinant Class I and Class II Collagenase for Successful Human Islet Isolation.

Authors:  Appakalai N Balamurugan; Michael L Green; Andrew G Breite; Gopalakrishnan Loganathan; Joshua J Wilhelm; Benjamin Tweed; Lenka Vargova; Amber Lockridge; Manikya Kuriti; Michael G Hughes; Stuart K Williams; Bernhard J Hering; Francis E Dwulet; Robert C McCarthy
Journal:  Transplant Direct       Date:  2015-12-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.